Testing effectiveness (Phase 2)Active Not RecruitingNCT04408625
What this trial is testing
Phase 1/2 Clinical Trial of LY3884963 in Patients With Frontotemporal Dementia With Progranulin Mutations (FTD-GRN)
Who this might be right for
Frontotemporal Dementia
Prevail Therapeutics 35